CPAP, weight loss, or both for obstructive sleep apnea

Abstract

Background: Obesity and obstructive sleep apnea tend to coexist and are associated with inflammation, insulin resistance, dyslipidemia, and high blood pressure, but their causal relation to these abnormalities is unclear.

Methods: We randomly assigned 181 patients with obesity, moderate-to-severe obstructive sleep apnea, and serum levels of C-reactive protein (CRP) greater than 1.0 mg per liter to receive treatment with continuous positive airway pressure (CPAP), a weight-loss intervention, or CPAP plus a weight-loss intervention for 24 weeks. We assessed the incremental effect of the combined interventions over each one alone on the CRP level (the primary end point), insulin sensitivity, lipid levels, and blood pressure.

Results: Among the 146 participants for whom there were follow-up data, those assigned to weight loss only and those assigned to the combined interventions had reductions in CRP levels, insulin resistance, and serum triglyceride levels. None of these changes were observed in the group receiving CPAP alone. Blood pressure was reduced in all three groups. No significant incremental effect on CRP levels was found for the combined interventions as compared with either weight loss or CPAP alone. Reductions in insulin resistance and serum triglyceride levels were greater in the combined-intervention group than in the group receiving CPAP only, but there were no significant differences in these values between the combined-intervention group and the weight-loss group. In per-protocol analyses, which included 90 participants who met prespecified criteria for adherence, the combined interventions resulted in a larger reduction in systolic blood pressure and mean arterial pressure than did either CPAP or weight loss alone.

Conclusions: In adults with obesity and obstructive sleep apnea, CPAP combined with a weight-loss intervention did not reduce CRP levels more than either intervention alone. In secondary analyses, weight loss provided an incremental reduction in insulin resistance and serum triglyceride levels when combined with CPAP. In addition, adherence to a regimen of weight loss and CPAP may result in incremental reductions in blood pressure as compared with either intervention alone. (Funded by the National Heart, Lung, and Blood Institute; ClinicalTrials.gov number, NCT0371293 .).

Trial registration: ClinicalTrials.gov NCT00371293 NCT00371293.

Figures

Figure 1. Numbers of Patients Who Were Screened, Randomly Assigned to a Study Group, and Included in Analyses

AHI denotes apnea–hypopnea index, BDI Beck Depression Inventory (in which scores range from 0 to 63, with higher scores indicating more severe depression), BMI body-mass index (the weight in kilograms divided by the square of the height in meters), CPAP continuous positive airway pressure, and CRP C-reactive protein. To convert the values for glucose to millimoles per liter, multiply by 0.05551.

Figure 2. Changes from Baseline in CRP in the Modified Intention-to-Treat and Per-Protocol Populations

Panel A shows changes in CRP levels in the modified intention-to-treat population, and Panel B shows changes in CRP levels in the per-protocol population. The per-protocol population consisted of participants who met prespecified adherence criteria. I bars represent 95% confidence intervals. P values without brackets are for the change from baseline in each group. P values with brackets are for between-group differences at week 24.

Figure 3 (facing page). Changes from Baseline in the Insulin Sensitivity Index, Serum Triglyceride Levels, and Systolic Blood Pressure in the Modified-Intention-to-Treat and Per-Protocol Populations

Panel A shows changes in the insulin sensitivity index, Panel B changes in serum triglyceride levels, and Panel C changes in systolic blood pressure. I bars represent 95% confidence intervals. P values without brackets are for the change from baseline in each group. P values with brackets are for between-group differences at week 24. To convert the values for triglycerides to millimoles per liter, multiply by 0.01129.